Cyclooxygenase-2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2474
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cyclooxygenase-2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees ; volume:17 ; number:1 ; day:24 ; month:10 ; year:2016 ; pages:1-10 ; date:12.2016
BMC musculoskeletal disorders ; 17, Heft 1 (24.10.2016), 1-10, 12.2016
- Creator
-
Ozawa, Junya
- Contributor
-
Kaneguchi, Akinori
Tanaka, Ryo
Kito, Nobuhiro
Moriyama, Hideki
SpringerLink (Online service)
- DOI
-
10.1186/s12891-016-1303-5
- URN
-
urn:nbn:de:1111-201611218943
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ozawa, Junya
- Kaneguchi, Akinori
- Tanaka, Ryo
- Kito, Nobuhiro
- Moriyama, Hideki
- SpringerLink (Online service)
Other Objects (12)
Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
Bezafibrate attenuates immobilization-induced muscle atrophy in mice
Fulvic acid attenuates homocysteine-induced cyclooxygenase-2 expression in human monocytes
Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells
Der selektive Cyclooxygenase-2-Inhibitor Celecoxib ist ein sicheres Ausweichpräparat bei Patienten mit Intoleranzen gegenüber nicht-steroidalen Antiphlogistika
Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo
Exercise intolerance and muscle contracture
Ischaemic contracture of the hand
Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line
12 Jahre Celecoxib – eine Bestandsaufnahme
Charakterisierung von T-Helferzellen und spezifisch zellulärer Immunität bei schizophrenen Patienten im Verlauf einer Therapie mit dem selektiven Cyclooxygenase-2-Hemmer Celecoxib
Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
Bezafibrate attenuates immobilization-induced muscle atrophy in mice
Fulvic acid attenuates homocysteine-induced cyclooxygenase-2 expression in human monocytes
Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells
Der selektive Cyclooxygenase-2-Inhibitor Celecoxib ist ein sicheres Ausweichpräparat bei Patienten mit Intoleranzen gegenüber nicht-steroidalen Antiphlogistika
Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo
Exercise intolerance and muscle contracture
Ischaemic contracture of the hand
Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line
12 Jahre Celecoxib – eine Bestandsaufnahme
Charakterisierung von T-Helferzellen und spezifisch zellulärer Immunität bei schizophrenen Patienten im Verlauf einer Therapie mit dem selektiven Cyclooxygenase-2-Hemmer Celecoxib
Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
Bezafibrate attenuates immobilization-induced muscle atrophy in mice
Fulvic acid attenuates homocysteine-induced cyclooxygenase-2 expression in human monocytes
Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells
Der selektive Cyclooxygenase-2-Inhibitor Celecoxib ist ein sicheres Ausweichpräparat bei Patienten mit Intoleranzen gegenüber nicht-steroidalen Antiphlogistika
Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo
Exercise intolerance and muscle contracture
Ischaemic contracture of the hand
Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line
12 Jahre Celecoxib – eine Bestandsaufnahme